References
Australian Productivity Commission Report, 2005, Impact of Medical Technology in Australia.
Bryant, J., Teasdale, A., Tobias, M., Cheung, J. and McHugh M. 2004, Population Ageing and Government Health Expenditures in New Zealand, 1951-2051, New Zealand Treasury Working Paper, 04/14.
Conaglen, P., Sebastian, C., Jayaraman, C., Abraham, A., Makkada, V. and Devlin, G. 2004, Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction: Do Cardiologists Do It Better? A Comparison of Secondary and Tertiary Centre Management in New Zealand, The New Zealand Medical Journal, Vol 117, No 1194.
District Health Boards New Zealand Incorporated and Ministry of Health, 2005, Service Planning and New Health Intervention Assessment: Framework for Collaborative Decision-Making.
Doolan-Noble, F., Broad, J., Riddell, T. and North, D. 2004, Cardiac Rehabilitation Services in New Zealand: Access and Utilisation, The New Zealand Medical Journal, Vol 117, No 1197.
Fuchs, V. and Sox, H. 2001, Physicians’ Views of the Relative Importance of Thirty Medical Innovations, Health Affairs, Volume 20, No 5, 30-42.
Hannan, E. L. et. al. 2005, Long Term Outcomes of Coronary Artery Bypass Grafting versus Stent Implantation, New England Journal of Medicine, 352, 2174-83.
Harris, J. 2005, Changing Priorities: Stents in Cardiovascular Care, Presentation to Wellington Health Economics Group, Health Services Research Centre, School of Government, Victoria University of Wellington.
Hill, R. et. al. 2004, Coronary Artery Stents: A Rapid Systematic Review and Economic Evaluation, Health Technology Assessment, 8, No. 35.
McLellan, M. and Kessler, D. 1999, A Global Analysis of Technological Change in Health Care: The Case of Heart Attacks, Health Affairs, Vol 18, No 3, 250-55.
McLellan, M. and Noguchi, H. 1998, Technological Change in Heart Disease Treatment. Does High Tech Mean Low Value? The American Economic Review, Vol 88, No 2, 90-96.
Ministry of Health, 2003, Guidelines for Capital Investment.
Ministry of Health, 2003, New Zealand health Strategy. DHB Toolkit. Cardiovascular Disease. To reduce the incidence of cardiovascular disease.
Ministry of Health, 2005, Business Case Guidelines for Investment in Information Technology.
National Health Committee on Health and Disability, 2005, Decision-Making about New Health Interventions, A Report to the New Zealand Minister of Health.
Newhouse, J. P. 1992, Medical Care Costs: How Much Welfare Loss? Journal of Economic Perspectives, Vol 6, No 3, 3-21.
PHARMAC Annual Review 2004.
Sharpe, N. and Wilkins, G. 2004, Quality and Equity in Cardiovascular Health in New Zealand: The Need for Agreed Achievable Standards of Care, Cohesive Planning and Action, The New Zealand Medical Journal, Vol 117, No 1197.
Wanless, D. 2001, Securing our Future Health: Taking a Long-Term View, Interim Report, HM Treasury, London.
Weinstein, M. C. 2003, Coronary Artery Bypass Surgery is Still Cost-Effective: Using Calibrated Models to Update Clinical Trials, American Journal of Medicine, 115, 410-11.
